Skip to main navigation Skip to search Skip to main content

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

Translated title of the contribution: Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.
  • S.C. Gouw
  • , J.G. van der Bom
  • , G. Auerswald
  • , C.E. Ettinghausen
  • , U. Tedgard
  • , H.M. van den Berg

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionRecombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.
Original languageUndefined/Unknown
Pages (from-to)4693-4697
Number of pages5
JournalBlood
Volume109
Issue number11
Publication statusPublished - 2007

Cite this